Max Wallace
Directeur/Membre du Conseil chez HUMACYTE, INC.
Fortune : 482 871 $ au 31/05/2024
Profil
Max Wallace is the founder of Sphinx Pharmaceuticals Corp, Sarco, Inc., DUMAC, Inc., Cogent Neuroscience, Inc., NC Life Sciences Organization.
He currently holds positions as Director at Biotechnology Innovation Organization, Director at Humacyte Global, Inc., Independent Director at Humacyte, Inc., and President at RoundTable Research LLC.
His former positions include Chief Executive Officer at Accelerate Brain Cancer Cure, Inc., Chief Executive Officer at TheraLogics, Inc., President at Trimeris, Inc., and President at Cogent.
He also worked as Legal Counsel at Duke University Medical Center.
Mr. Wallace received his undergraduate degree from Duke University and his graduate degree from the University of Florida.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
HUMACYTE, INC.
0,05% | 13/06/2024 | 64 555 ( 0,05% ) | 482 871 $ | 31/05/2024 |
Postes actifs de Max Wallace
| Sociétés | Poste | Début |
|---|---|---|
| HUMACYTE, INC. | Directeur/Membre du Conseil | 26/08/2021 |
Humacyte Global, Inc.
 Humacyte Global, Inc. Medical SpecialtiesHealth Technology Humacyte Global, Inc. engages in the manufacture of human acellular matrix products for vascular and non-vascular applications. It offers its products to the cardiovascular, cosmetic, soft tissue reconstruction, neurosurgical, and orthopedic markets. The company was founded by Laura E. Niklason, Juliana L. Blum and Shannon L. M. Dahl in 2004 and is headquartered in Durham, NC. | Directeur/Membre du Conseil | 01/01/2005 |
| RoundTable Research LLC | President | - |
Biotechnology Innovation Organization
 Biotechnology Innovation Organization Miscellaneous Commercial ServicesCommercial Services Biotechnology Innovation Organization is the world's biotechnology organization, providing advocacy, business development and communications services for more than 1,200 members worldwide. BIO members are involved in the research and development of innovative healthcare, agricultural, industrial and environmental biotechnology technologies. Corporate members range from entrepreneurial companies developing a first product to Fortune 100 multinationals. also represent state and regional biotech associations, service providers to the industry and academic centers. | Directeur/Membre du Conseil | - |
Anciens postes connus de Max Wallace
| Sociétés | Poste | Fin |
|---|---|---|
Accelerate Brain Cancer Cure, Inc.
 Accelerate Brain Cancer Cure, Inc. Miscellaneous Commercial ServicesCommercial Services Accelerate Brain Cancer Cure, Inc. drives cutting-edge research and treatments for brain tumors. The firm specializes in venture philanthropy, brain cancer research and brain tumor research. The company was founded by Stacey Case, Stephen M. Case and Jean Case in 2001 and is headquartered in | Directeur Général | 01/12/2019 |
| Duke University Medical Center | Conseiller Juridique Général | - |
NC Life Sciences Organization
 NC Life Sciences Organization Miscellaneous Commercial ServicesCommercial Services North Carolina Biosciences Organization is non-profit organization, which focuses on legislative monitoring and lobbying activities at the state and federal level. The company was founded in 1994 and is headquartered in Durham, NC. | Fondateur | - |
| Cogent Neuroscience, Inc. | Fondateur | - |
| TheraLogics, Inc. | Directeur Général | - |
Formation de Max Wallace
| Duke University | Undergraduate Degree |
| University of Florida | Graduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| HUMACYTE, INC. | Health Technology |
| Entreprise privées | 12 |
|---|---|
Trimeris, Inc.
 Trimeris, Inc. Pharmaceuticals: MajorHealth Technology Trimeris, Inc. develops therapeutics for viral diseases. It is a biopharmaceutical company engaged in the discovery, development and commercialization of novel therapeutic agents for the treatment of viral disease. The core technology platform of fusion inhibition is based on blocking viral entry into host cells. The company was founded in 1993 and is headquartered in Durham, NC. | Health Technology |
Biotechnology Innovation Organization
Biotechnology Innovation Organization Miscellaneous Commercial ServicesCommercial Services Biotechnology Innovation Organization is the world's biotechnology organization, providing advocacy, business development and communications services for more than 1,200 members worldwide. BIO members are involved in the research and development of innovative healthcare, agricultural, industrial and environmental biotechnology technologies. Corporate members range from entrepreneurial companies developing a first product to Fortune 100 multinationals. also represent state and regional biotech associations, service providers to the industry and academic centers. | Commercial Services |
Humacyte Global, Inc.
Humacyte Global, Inc. Medical SpecialtiesHealth Technology Humacyte Global, Inc. engages in the manufacture of human acellular matrix products for vascular and non-vascular applications. It offers its products to the cardiovascular, cosmetic, soft tissue reconstruction, neurosurgical, and orthopedic markets. The company was founded by Laura E. Niklason, Juliana L. Blum and Shannon L. M. Dahl in 2004 and is headquartered in Durham, NC. | Health Technology |
| Sphinx Pharmaceuticals Corp | Health Technology |
| Sarco, Inc. | Commercial Services |
Cogent
 Cogent Information Technology ServicesTechnology Services Cogent develops integrated office solutions such as software, maintenance services, and cost systems. Its services include unified communication and collaboration, network management, pbx system solutions and managed services. The company is headquartered in Auckland, New Zealand. | Technology Services |
DUMAC, Inc.
 DUMAC, Inc. Investment ManagersFinance DUMAC, Inc. is the investment arm of Duke University, a private research university headquartered in Durham, North Carolina. Founded in 1989, the firm manages Duke University’s endowment assets. In addition to managing Duke’s endowment, DUMAC also manages the university’s defined benefit pension plan assets, Duke University Health System’s investments, and much of the university’s working capital. DUMAC also manages the assets of The Duke Endowment, the private charitable trust established by Duke University’s founder, James B. Duke. | Finance |
NC Life Sciences Organization
NC Life Sciences Organization Miscellaneous Commercial ServicesCommercial Services North Carolina Biosciences Organization is non-profit organization, which focuses on legislative monitoring and lobbying activities at the state and federal level. The company was founded in 1994 and is headquartered in Durham, NC. | Commercial Services |
Accelerate Brain Cancer Cure, Inc.
Accelerate Brain Cancer Cure, Inc. Miscellaneous Commercial ServicesCommercial Services Accelerate Brain Cancer Cure, Inc. drives cutting-edge research and treatments for brain tumors. The firm specializes in venture philanthropy, brain cancer research and brain tumor research. The company was founded by Stacey Case, Stephen M. Case and Jean Case in 2001 and is headquartered in | Commercial Services |
| Cogent Neuroscience, Inc. | |
| TheraLogics, Inc. | |
| RoundTable Research LLC |
